CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 63 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TUDOR INVESTMENT CORP ET AL | 44,730 | $57,702 | 0.00% |
| Private Advisor Group, LLC | 73,179 | $94,401 | 0.00% |
| Squarepoint Ops LLC | 173,625 | $223,976 | 0.00% |
| MARSHALL WACE, LLP | 377,593 | $487,095 | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 145,934 | $188,255 | 0.00% |
| Tower Research Capital LLC (TRC) | 8,231 | $10,618 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 698,906 | $901,589 | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 24,817 | $32,014 | 0.00% |
| MORGAN STANLEY | 63,660 | $82,121 | 0.00% |
| Invesco Ltd. | 22,071 | $28,472 | 0.00% |
| MACKENZIE FINANCIAL CORP | 15,637 | $19,390 | 0.00% |
| BlackRock Inc. | 1,139,636 | $1,470,130 | 0.00% |
| Bank of New York Mellon Corp | 266,836 | $344,218 | 0.00% |
| LPL Financial LLC | 105,392 | $135,956 | 0.00% |
| Citadel Advisors | 34,500 | $44,505 | 0.00% |
| Citadel Advisors | 3,400 | $4,386 | 0.00% |
| Citadel Advisors | 60,166 | $77,614 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 88,570 | $114,255 | 0.00% |
| TWO SIGMA ADVISERS, LP | 107,900 | $139,191 | 0.00% |
| Qube Research & Technologies Ltd | 259 | $334 | 0.00% |
External links
This page lists CYTOMX THERAPEUTICS INC's shareholders in Q3 2023. To view CYTOMX THERAPEUTICS INC's shareholder history, click here.